US Stock MarketDetailed Quotes

BTAI BioXcel Therapeutics

Watchlist

0.509
-0.062-10.80%

Close Nov 22 16:00 ET

0.510
+0.001+0.20%

Post 20:01 ET

21.76MMarket Cap-249P/E (TTM)

BioXcel Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

56.53%-16.34M

39.34%-23.17M

66.18%-17.71M

-14.53%-155.01M

30.48%-26.86M

-20.52%-37.58M

-15.42%-38.21M

-61.52%-52.35M

-64.74%-135.34M

-93.85%-38.64M

Net income from continuing operations

72.96%-13.65M

84.49%-8.3M

49.26%-26.79M

-8.02%-179.05M

59.39%-22.26M

-20.76%-50.49M

-42.06%-53.52M

-67.76%-52.8M

-55.01%-165.76M

-109.79%-54.81M

Operating gains losses

-481,900.00%-4.82M

-2,104.40%-12.04M

-112.99%-30K

-206.08%-436K

-125.74%-122K

--1K

---546K

--231K

793.48%411K

--474K

Depreciation and amortization

-2.53%77K

-4.94%77K

-2.50%78K

-2.75%318K

-3.70%78K

-7.06%79K

-3.57%81K

3.90%80K

10.10%327K

6.58%81K

Other non cash items

75.49%1.51M

73.83%1.45M

66.54%1.33M

82.30%3.53M

4.11%1.04M

38.87%861K

--833K

--801K

--1.94M

--997K

Change In working capital

-116.65%-1.32M

-161.48%-5.42M

176.99%4.27M

-80.60%2.02M

-191.36%-9.2M

44.60%7.95M

2,855.31%8.82M

-14.52%-5.55M

108.90%10.4M

159.47%10.07M

-Change in receivables

366.12%809K

-193.24%-434K

-777.14%-307K

171.37%177K

367.74%664K

---304K

---148K

---35K

---248K

-Change in inventory

1,341.94%1.16M

-992.59%-241K

-1,457.58%-448K

99.70%-6K

104.68%27K

-615.38%-93K

103.79%27K

104.84%33K

---1.99M

---577K

-Change in prepaid assets

-164.82%-1.46M

-131.03%-459K

144.92%901K

173.96%2.89M

13.12%1.16M

5.29%2.25M

141.17%1.48M

42.36%-2.01M

-3,891.26%-3.91M

-44.14%1.03M

-Change in payables and accrued expense

-128.18%-1.74M

-155.72%-4.2M

221.55%4.21M

-104.29%-722K

-208.18%-10.97M

82.88%6.17M

88.87%7.54M

-411.98%-3.46M

247.09%16.83M

396.48%10.14M

-Change in other current liabilities

-8.64%-88K

-10.13%-87K

-7.79%-83K

-8.87%-319K

-9.33%-82K

-9.46%-81K

-8.22%-79K

-8.45%-77K

-23.63%-293K

-8.70%-75K

Cash from discontinued investing activities

Operating cash flow

56.53%-16.34M

39.34%-23.17M

66.18%-17.71M

-14.53%-155.01M

30.48%-26.86M

-20.52%-37.58M

-15.42%-38.21M

-61.52%-52.35M

-64.74%-135.34M

-93.85%-38.64M

Investing cash flow

Cash flow from continuing investing activities

85.61%-20K

68.76%-139K

Net PPE purchase and sale

--0

----

85.61%-20K

--0

----

68.76%-139K

--0

Cash from discontinued investing activities

Investing cash flow

--0

85.61%-20K

--0

-5.26%-20K

--0

68.76%-139K

--0

Financing cash flow

Cash flow from continuing financing activities

454K

2,021.60%5.3M

10.26%26.63M

-72.44%26.52M

4,146.00%2.12M

-99.62%250K

24.15M

-6.06%96.24M

50K

Net issuance payments of debt

----

--0

----

--98.6M

--0

Net common stock issuance

--468K

--5.48M

8.46%26.74M

--27.03M

--2.38M

--0

--24.66M

--0

Proceeds from stock option exercised by employees

--0

79.51%508K

--0

35.14%250K

--258K

-80.54%283K

--50K

Net other financing activities

---14K

---172K

84.73%-117K

61.53%-1.02M

---252K

--0

---766K

---2.65M

--0

Cash from discontinued financing activities

Financing cash flow

--454K

2,021.60%5.3M

10.26%26.63M

-72.44%26.52M

4,146.00%2.12M

--0

-99.62%250K

--24.15M

-6.06%96.24M

--50K

Net cash flow

Beginning cash position

-55.88%56.27M

-55.21%74.14M

-66.33%65.22M

-16.84%193.73M

-61.28%89.96M

-45.37%127.55M

-17.42%165.52M

-16.84%193.73M

9.31%232.97M

-8.14%232.31M

Current changes in cash

57.74%-15.88M

52.94%-17.87M

131.63%8.92M

-227.46%-128.5M

35.89%-24.74M

-3,202.64%-37.58M

-215.02%-37.98M

13.31%-28.2M

-297.71%-39.24M

-93.49%-38.59M

End cash Position

-55.11%40.39M

-55.88%56.27M

-55.21%74.14M

-66.33%65.22M

-61.28%89.96M

-45.37%127.55M

-17.42%165.52M

-16.84%193.73M

Free cash flow

56.53%-16.34M

39.38%-23.17M

66.18%-17.71M

-14.43%-155.03M

30.48%-26.86M

-20.52%-37.58M

-15.41%-38.23M

-60.92%-52.35M

-64.02%-135.48M

-93.74%-38.64M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	56.53%-16.34M	39.34%-23.17M	66.18%-17.71M	-14.53%-155.01M	30.48%-26.86M	-20.52%-37.58M	-15.42%-38.21M	-61.52%-52.35M	-64.74%-135.34M	-93.85%-38.64M
Net income from continuing operations	72.96%-13.65M	84.49%-8.3M	49.26%-26.79M	-8.02%-179.05M	59.39%-22.26M	-20.76%-50.49M	-42.06%-53.52M	-67.76%-52.8M	-55.01%-165.76M	-109.79%-54.81M
Operating gains losses	-481,900.00%-4.82M	-2,104.40%-12.04M	-112.99%-30K	-206.08%-436K	-125.74%-122K	--1K	---546K	--231K	793.48%411K	--474K
Depreciation and amortization	-2.53%77K	-4.94%77K	-2.50%78K	-2.75%318K	-3.70%78K	-7.06%79K	-3.57%81K	3.90%80K	10.10%327K	6.58%81K
Other non cash items	75.49%1.51M	73.83%1.45M	66.54%1.33M	82.30%3.53M	4.11%1.04M	38.87%861K	--833K	--801K	--1.94M	--997K
Change In working capital	-116.65%-1.32M	-161.48%-5.42M	176.99%4.27M	-80.60%2.02M	-191.36%-9.2M	44.60%7.95M	2,855.31%8.82M	-14.52%-5.55M	108.90%10.4M	159.47%10.07M
-Change in receivables	366.12%809K	-193.24%-434K	-777.14%-307K	171.37%177K	367.74%664K	---304K	---148K	---35K	---248K	---248K
-Change in inventory	1,341.94%1.16M	-992.59%-241K	-1,457.58%-448K	99.70%-6K	104.68%27K	-615.38%-93K	103.79%27K	104.84%33K	---1.99M	---577K
-Change in prepaid assets	-164.82%-1.46M	-131.03%-459K	144.92%901K	173.96%2.89M	13.12%1.16M	5.29%2.25M	141.17%1.48M	42.36%-2.01M	-3,891.26%-3.91M	-44.14%1.03M
-Change in payables and accrued expense	-128.18%-1.74M	-155.72%-4.2M	221.55%4.21M	-104.29%-722K	-208.18%-10.97M	82.88%6.17M	88.87%7.54M	-411.98%-3.46M	247.09%16.83M	396.48%10.14M
-Change in other current liabilities	-8.64%-88K	-10.13%-87K	-7.79%-83K	-8.87%-319K	-9.33%-82K	-9.46%-81K	-8.22%-79K	-8.45%-77K	-23.63%-293K	-8.70%-75K
Cash from discontinued investing activities
Operating cash flow	56.53%-16.34M	39.34%-23.17M	66.18%-17.71M	-14.53%-155.01M	30.48%-26.86M	-20.52%-37.58M	-15.42%-38.21M	-61.52%-52.35M	-64.74%-135.34M	-93.85%-38.64M
Investing cash flow
Cash flow from continuing investing activities	0			85.61%-20K	0	0			68.76%-139K	0
Net PPE purchase and sale	--0	----	----	85.61%-20K	--0	--0	----	----	68.76%-139K	--0
Cash from discontinued investing activities
Investing cash flow	--0	--0	--0	85.61%-20K	--0	--0	-5.26%-20K	--0	68.76%-139K	--0
Financing cash flow
Cash flow from continuing financing activities	454K	2,021.60%5.3M	10.26%26.63M	-72.44%26.52M	4,146.00%2.12M	0	-99.62%250K	24.15M	-6.06%96.24M	50K
Net issuance payments of debt	----	----	----	--0	----	----	----	----	--98.6M	--0
Net common stock issuance	--468K	--5.48M	8.46%26.74M	--27.03M	--2.38M	--0	--0	--24.66M	--0	--0
Proceeds from stock option exercised by employees	--0	--0	--0	79.51%508K	--0	--0	35.14%250K	--258K	-80.54%283K	--50K
Net other financing activities	---14K	---172K	84.73%-117K	61.53%-1.02M	---252K	--0	--0	---766K	---2.65M	--0
Cash from discontinued financing activities
Financing cash flow	--454K	2,021.60%5.3M	10.26%26.63M	-72.44%26.52M	4,146.00%2.12M	--0	-99.62%250K	--24.15M	-6.06%96.24M	--50K
Net cash flow
Beginning cash position	-55.88%56.27M	-55.21%74.14M	-66.33%65.22M	-16.84%193.73M	-61.28%89.96M	-45.37%127.55M	-17.42%165.52M	-16.84%193.73M	9.31%232.97M	-8.14%232.31M
Current changes in cash	57.74%-15.88M	52.94%-17.87M	131.63%8.92M	-227.46%-128.5M	35.89%-24.74M	-3,202.64%-37.58M	-215.02%-37.98M	13.31%-28.2M	-297.71%-39.24M	-93.49%-38.59M
End cash Position	-55.11%40.39M	-55.88%56.27M	-55.21%74.14M	-66.33%65.22M	-66.33%65.22M	-61.28%89.96M	-45.37%127.55M	-17.42%165.52M	-16.84%193.73M	-16.84%193.73M
Free cash flow	56.53%-16.34M	39.38%-23.17M	66.18%-17.71M	-14.43%-155.03M	30.48%-26.86M	-20.52%-37.58M	-15.41%-38.23M	-60.92%-52.35M	-64.02%-135.48M	-93.74%-38.64M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data